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The placebo effect is
ubiquitous, being
present in every
patient–treatment
situation. In the era
of prescientific
medicine, the
reputation of healers
was built largely
upon the power of
this effect. In modern
medicine the effect
continues, and may
be harnessed to
enhance sound
scientific treatment
and thus facilitate
recovery.
As Sir William Osler once said:
‘The desire to take medicine is one fea-
ture which distinguishes man, the ani-
mal, from his fellow creatures. It really
is one of the most serious difficulties
with which we have to contend’ (Osler,
1894).
From time immemorial, man has felt the
need to self-medicate, and to seek help
from healers in times of mental and physi-
cal distress. In the days of prescientific
medicine, the pills, potions and procedures
dispensed by healers were seldom pharma-
cologically active. When preparations did
contain active ingredients, they were
potentially harmful to those ingesting or
applying them. Details of such prepara-
tions are to be found in any text on the his-
tory of medicine, and include such items as
frog sperm, crocodile dung, dried viper
lozenges, oil of ants, moss scraped from the
skulls of victims of violent deaths and
eunuch fat (Shapiro, 1971).
Despite the administration of such
bizarre prescriptions, physicians and other
healers maintained a position in society
which was then (as now) prestigious and of
high esteem. Their success was due to two
phenomena which worked in harmony
towards the achievement of human recov-
ery: first, the human homeostatic propen-
sity, which was directly responsible for the
self-limitation of many pathologies, and
second, the powerful and ubiquitous
placebo effect. This second effect may
indeed be thought of as an extension of the
first. Thus the placebo effect has the poten-
tial to facilitate the ability to self-heal
which lies within us all.
Pleasing the patient
The word placebo stems from the Latin
placere which means ‘to please’. One of the
earliest occurrences in medical literature is
recorded in Hooper’s Medical Dictionary in
1811, where it was described as: 
‘...an epithet given to any medicine
adopted more to please than to benefit
the patient.’ 
The tone of this definition captures the
faint air of disapproval with which placebo
administration was (and to a large extent
still is) viewed by the medical profession.
However, even four decades ago, when
the word ‘placebo’ first appeared in the
title of a medical paper (Wolf et al, 1946), it
had its protagonists. The authors objected
to the definition given above, arguing very
reasonably that if a patient is pleased, then
he is also benefited by his treatment — an
early acknowledgement, perhaps, of the
importance of consumer satisfaction in the
presentation of clinical treatment.
Placebo has been redefined in medical
literature many times. A useful, neutral
definition is offered by Shapiro (1971): 
‘...any therapy, or that component of
any therapy, that is deliberately used
for its non-specific, psychologic or psy-
chophysiologic effect, or that is used for
its presumed scientific effect on a
patient, symptom or illness, but which,
unknown to patient and therapist, is
without specific activity for the condi-
tion being treated.’
In this analysis, Shapiro extends the defini-
tion beyond the commonly held view, i.e.
the administration of a sugar pill by the
knowing doctor to the ignorant patient, to
one that is broader in its perspective. The
term now also includes any therapeutic
procedure which is assumed by both
patient and therapist to be specifically
active in relation to a particular problem,
but which, in reality, cannot and does not
have any specific effect upon the condition
being treated.
The ubiquitous placebo effect
This perspective was enlarged upon by
Epstein (1984) when he stated: 
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‘At the point
when scientific
medicine was
born, the holistic,
consumer-oriented
approach to
medical
management
suffered a demise.
The art of
medicine was
largely lost as the
science of
medicine was
delivered. The
preoccupation of
doctors now lay
with the patient as
a medical
condition, rather
than the patient as
a person.’
‘The placebo effect also occurs with all
active or real treatments’. 
The placebo effect is ubiquitous (Abel,
1991). Every time there is a clinical
encounter between doctor or therapist and
patient, the placebo effect forms part of
that encounter.
Thus the history of prescientific medicine
was primarily the history of the placebo
effect. With the advent of scientific medi-
cine, former quackeries were recognized as
such, and were rapidly cast into disrepute.
There was a complete metamorphosis of
medical opinion, catalysed by the germ
theories of Pasteur and Koch:
‘They imposed upon medical thought;
they transfixed its theoretical and
philosophical corpus with the vivid
concept of the specific aetiological fac-
tor, and by necessity also with its corol-
lary, the specific antidotal curative
agent’ (Galdston, 1954).
Every disease was therefore seen to stem
from a specific cause, which necessitated
treatment by a similarly specific agent.
Treatment was demanded by the patient
and administered by doctors.
At the point when scientific medicine
was born, the holistic, consumer-oriented
approach to medical management suffered
a demise. The art of medicine was largely
lost as the science of medicine was deliv-
ered. The preoccupation of doctors now
lay with the patient as a medical condition,
rather than the patient as a person.
But what of the powerful placebo
effect? Had it been ‘switched off’ as it was
superseded by the new era of modern
medicine? Testimony to the continued
existence of the phenomenon came from
controlled drug studies, which were initi-
ated from the 1950s. However, the
placebo effect was not considered a useful
one at this time, being viewed with dis-
favour as a potential contaminant of
research findings.
How effective is placebo?
When making a quantitative assessment of
placebo effectiveness it is necessary to
look at both the types of condition and
also the number of patients within any
treatment group who may have their
symptoms eased or alleviated by placebo
administration. The use of a placebo con-
trol in clinical trials has produced a wealth
of information in these areas. Thousands
of medical papers include the word
‘placebo’ in their title. There are too many
of these to even begin to list here, but ref-
erence to this body of material will
demonstrate that the placebo response is
efficacious in facilitating recovery at a sta-
tistically significant level in a wide variety
of disparate conditions. These include sur-
gical pain, gastric ulceration, hyperten-
sion, diabetes, nausea, clinical anxiety and
depression, status asthmaticus, schizo-
phrenia, arthralgia, cancer, tinnitus and
the common cold. 
There are very many more examples.
Indeed, Haegerstam et al (1982) stated
that:
‘Nearly every organ system in the body
can respond to placebo treatment.’
A characteristic level of efficacy for the
placebo response was identified in the
1950s by Beecher:
‘It is evident that placebos have a high
degree of therapeutic effectiveness in
treating subjective responses, decided
improvement, interpreted under the
unknown technique as a real therapeu-
tic effect, being produced in 35.2 ± 2.2%
of cases. This is shown in over 1000
patients in 15 studies covering a variety
of areas...’
The value of 35% efficacy in producing a
therapeutic effect has been observed many
times since in clinical trials. However, the
placebo effect can be considerably greater
than this under the appropriate conditions.
Spiro (1986) noted that in double-blind
controlled trials conducted in patients with
duodenal ulceration, 50–60% of ulcers
healed with placebo therapy, whereas
about 70% healed with a specific drug
treatment. However, there is no absolute
value of placebo response for every indi-
vidual condition. Spiro reported differ-
ences in healing rates for duodenal ulcer
craters, ranging from 20% in London to
70% in Switzerland for patients receiving
placebo therapy. He also cited an identical
drug trial carried out in London and
Dundee, where the efficacy of the placebo
response in achieving healing of known
duodenal ulcer craters was 44% in London
compared with 74% in Dundee. Reasons
for this variation in placebo response rate
remain unclear. 
Beecher (1955) noted that 75% of a
patient group in severe post-operative pain
had their symptoms relieved by a large
dose of morphine, whereas 35% achieved
the same level of relief from a normal
saline placebo. He reasoned that:
‘The placebo effect of active drugs is
masked by their effects. The power
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attributed to morphine is then pre-
sumably a placebo effect plus its drug
effect.  The total “drug” effect is
“active” effect plus its placebo effect’
(Beecher, 1955).
According to Beecher, half of the effect of
a postoperative injection of morphine may
be accounted for by the placebo response.
It may therefore be deduced that placebo
therapy can be half as powerful as mor-
phine in producing relief from pain (Table
1).
Is it not extraordinary that a clinical tool
which has been shown to be both wide
ranging and potent in its effectiveness
should be so under-utilized in the treat-
ment of patients? Price (1984) expresses a
similar puzzlement:
‘If the pharmaceutical industry were to
produce a drug which was as reliable,
of such wide ranging applicability and
with a record of efficacy as impressive
as that of the placebo effect, it would
no doubt be proclaimed a miracle
panacea, and attributed to the wonders
of science.’
Factors generating the 
placebo response
Having identified the potential potency of
the placebo effect in terms of both num-
bers of patients and variety of conditions
likely to respond, the next step is to iden-
tify the factors involved in initiating this
effect (Figure 1).
Such factors may be divided into three
main categories:
 Characteristics of the patient
 Characteristics of the doctor/therapist
 Characteristics of the treatment situa-
tion.
Who responds to placebo?
A plethora of information exists concern-
ing the personality and social characteris-
tics of the placebo responder. Evidence is
either non-conclusive or conflicting, and
the general consensus is that there is no set
of predictors which accurately describe a
potential placebo responder (Gowdey,
1983; Reimherr et al, 1989; Lanvin, 1991;
Wall, 1993; Turner et al, 1994).
It seems that anxious patients respond
well to placebo (Wolf, 1959; Moertel et al,
1976; Fields and Levine, 1981; Bech, 1989),
but in each case this is related to a particu-
lar emotional state stemming from stress
(probably largely caused by their illness
and not a habitual personality trait).
It seems that all persons, subject to suit-
able environmental conditions, might
exhibit a positive response to placebo.
However, the response is so variable that
there will be no greater likelihood than
may be described by chance that a person
who responds to placebo in one situation
will respond in another, even in the course
of the same study (Beecher, 1955; Moertel
et al, 1976; Lasagna, 1979; Brody, 1980;
Wall, 1993). Thus, although 30–50% of a
population are likely to respond to placebo
in a variety of situations, it will not always
be the same people who will be responders
or non-responders.
Although no consistent findings have
emerged to identify a ‘placebo personality’,
many medical personnel express a common
prejudice in their opinion of the person
most likely to react to a non-specific treat-
ment. Vogel et al (1980), for example, state:
‘A common opinion among physicians
is that only individuals who are psycho-
logically defective, neurotic, suggestible,
hysterical, over-reactive or weak willed
will respond to placebo — that is, there
must be something wrong with a per-
son if he responds to placebo.’ 
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Drug effect = active ingredient effect + placebo effect
Drug effect – placebo effect = active ingredient 
(This is the classic ‘clinical trial’) effect
Drug effect – active ingredient effect = placebo effect
In the Beecher trial (1955) 
Drug effect – active ingredient effect = placebo effect
at 75% at 35% at 30%
Table 1. Relationship of placebo component effect to total drug effect
1
Patient 
characteristics
The 
placebo 
effect
2
Therapist
characteristics
3
Treatment
characteristics
Figure 1. Component factors which may generate the placebo effect.
Evidence indicates that the patient who
responds to placebo has a high level of pain
or other clinical need about which they are
anxious, has the capability for self-help and
mastery, and has enjoyed favourable expe-
riences in the hands of health professionals
in the past (Brody, 1980; Shapiro et al,
1980; Levine et al, 1981; Olsson et al,
1989). Thus a placebo responder can be
described as a patient whose need is great,
and whose faith in the ability of health-
care professionals to provide assistance is
also great.
These findings contrast sadly with the
opinions that medical staff are likely to
hold about such patients. Goodwin et al
(1979) cite a quote from a senior resident
on his perception of placebo use: 
‘Placebos are used with people you hate,
not to make them suffer, but to prove
them wrong.’
Thus it is the patient with the greatest
need and the greatest faith who is likely to
respond, but if medical staff discover that a
patient has responded in this way, then
they are likely to despise the patient for
that response and assume, quite incor-
rectly, that their symptoms must have been
imaginary (Kapp, 1983).
Who elicits the placebo response?
In the Western world, people who occupy
healing roles, whether they be doctor,
physiotherapist, herbalist or osteopath, are
popularly endowed with a much higher
status than their abilities deserve (Doongaji
et al, 1978; Totman, 1979; Zimba and
Buggie, 1993). This can lead to unrealistic
expectations among patients about healers’
capacity to effect a cure (Galdston, 1954;
Gryll and Katahn, 1978).
The environment in which health service
personnel operate can further contribute to
the mystique, acting as a stage setting in
which the therapeutic interaction takes
place. This setting is filled with insignia of
the healing process: expensive equipment,
documentation involving strange symbols,
the presence of other sufferers of physical
ailments also seeking help, and a general
pervasive sensation of strangeness engen-
dered by unusual smells, sounds and
sights. A patient may enter such an envi-
ronment with a need for help and an
expectation that this will be provided —
factors which may predispose them to a
positive placebo response. 
In addition to the predisposing factors
that a patient brings with him/her into a
health-care environment, factors associ-
ated with the therapist have the capacity
to increase a patient’s ability to self-heal.
Key factors in the interaction between the
therapist and patient which are asserted
with a placebo response are warmth and
social support, status, empathy, provision
of information, overt interest in the
patient and his condition, and, most
importantly, the capacity to generate pos-
itive expectations of outcomes (Buchalew,
1972; Beck, 1977; Brody, 1980; Lyno,
1990). Thus patient factors may combine
with therapist factors to activate the
placebo effect. This is the important
process of iatroplacebogenesis.
Gryll and Katahn (1978) attempted to
quantify some of these factors. They sum-
marized their findings as follows:
‘Each of the four independent variables
investigated (status of placebo adminis-
trator, attitudes of dentists and dental
technicians towards the patient and the
type of message about the expected
drug effects) affected the patient’s
responses to placebo administration:
the most salient of the four variables
was the type of information contained
in the message of drug effects...The
importance of the status variable
emerged only within the interplay
among the four situational variables
under investigation’.
Thus the healer who is most likely to
activate the placebo response in a patient
will be one who combines competence and
confidence with a warm and caring atti-
tude towards the patient, and who gives
implicit and explicit positive communica-
tion concerning expected treatment out-
comes (Lehrman, 1993; Wall, 1993)
(Figure 2). This illustrates the great para-
dox concerning iatroplacebogenesis
(Shapiro, 1969), i.e. that it is the most pro-
ficient administrator of specific physical
treatments who will engender the greatest
placebo effect. This in turn can supple-
ment the already sound clinical procedure
to maximize the beneficial outcome of
treatment.
However, if negative statements which
express doubt are made, by personnel who
express little warmth or interest in the
patient, the placebo effect may be actively
noxious, working against scientific treat-
ment to produce deleterious treatment out-
comes (Wolf, 1959; Wickrameskera, 1980;
Fields and Levine, 1981; Butler et al, 1983;
Barrie, 1984). When summarizing the
results of an experiment conducted into
the efficacy of certain tranquillizing drugs,
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‘Evidence 
indicates that the
patient who
responds to 
placebo has a high
level of pain or
other clinical need
about which they
are anxious, has
the capability for
self-help and 
mastery, and has
enjoyed
favourable 
experiences in the
hands of health
professionals in
the past...’
where the degree of enthusiasm for the
product by the doctor utilizing it was
included in the study details, Wolf (1959)
wrote:
‘The correlation showed that those
patients that had done best were in the
group treated by the doctors who like
the drug best. Those who did poorly
were patients of the therapeutic
nihilists.’
Which treatments generate a
placebo effect?
Because most of the information in this
area has been obtained from clinical drug
trials, much of the research evidence is
concerned with the manner in which a
drug is administered, in terms of method
of administration, colour, size and dosage
(Shapira et al, 1970; Evans, 1974a;
Huskisson, 1974; Buchalew and Coffield,
1982).
It was two decades ago that Lasagna
(1979) noted that a drug could have a vari-
able placebo effect depending upon its
characteristics. He found the placebo effect
to be greatest when tablets were either very
large or very small, and suggested that the
large tablets impressed by sheer size, while
the small ones impressed by their assumed
potency.
Treatments that are unpleasant, either
because of their taste (Evans, 1974b) or
their side-effects (Thomson, 1982), can also
act as potent placebos. Perhaps, like the
witches’ brew, the medicaments present as
being so unpleasant that they are perceived
as being very powerful.
In each case, it can be argued that the key
feature of a treatment which will trigger
the placebo response is an ability to
impress the patient with its potential
potency as a healing agent (Figure 3). Once
again the key process is the generation of
expectations of success in terms of treat-
ment outcome.
Overall, the more specialized, fashion-
able, powerful, costly and complex a
patient perceives a treatment to be, the
stronger will be the placebo effect which
runs alongside and reinforces that treat-
ment (Beck, 1977; Lasagna, 1979;
Buchalew and Ross, 1981). Hence open
heart surgery is likely to be more active in
its non-specific effects than a less major
operation, intermittent traction given on
expensive equipment more active than
manual traction, and a drug given by injec-
tion more active in its non-specific effects
than the same drug given in tablet form
(particularly if the tablet is white and of
medium size).
The potential of placebo
The placebo effect will therefore be great-
est when patients who have severe clinical
problems approach clinicians in whom
they have great faith. If those clinicians are
clearly interested in their case, have a warm
and caring attitude, are willing to listen,
give them information and specialized
British Journal of Therapy and Rehabilitation, March 1996, Vol 3, No 3162
Iatroplacebogenesis: a useful therapeutic tool?
Figure 3. The key feature of a treatment which will trigger the placebo
response is an ability to impress the patient with its potential potency
as a healing agent.
Figure 2. Combining competence and con-
fidence with a warm and caring attitude.
treatment, and above all engender the
expectation that they have the capacity to
help the patient, then there is a very strong
possibility that the placebo effect will be
activated in a positive direction. 
The placebo effect forms part of every
interaction between patient and clinician. If
utilized wisely it may supplement and
enhance scientific medical procedures and
substantially increase their effectiveness. If
abused it may operate against such treat-
ments and actively reduce their efficacy.
Medicine as art and medicine as science
operate harmoniously when the placebo
effect is utilized with insight to reinforce a
scientific treatment procedure. In this man-
ner, the capacity for self-healing which
resides within us all may receive maximal
stimulation.
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KEY POINTS
 The placebo effect operates to facilitate the process of self-
healing.
 It can be effective at a significant level in all body systems.
 It is present in every patient–treatment situation.
 It works best with patients who are most ill.
 Used wisely, it will supplement and complement the
scientific effects of all treatments.
